News

Cobra Biomanufacturing and ViroMed extend collaboration for R&D

Keele, UK
Jul 24, 2008

Cobra Biomanufacturing Plc announced that it has entered into an agreement with ViroMed Co. Ltd and has planned to form a manufacturing joint venture with the latter. The two companies have intended collaboration for long term research, development and technical consultancy agreement for all ViroMed products. Under the agreement ViroMed will be provided with guaranteed process development and manufacturing resources. The two companies are also to explore the potential of establishing a joint venture biomanufacturing company for the manufacture of ViroMed products.

Speaking on this, Simon Saxby, CEO, Cobra Biomanufacturing said, “The further development of our partnership with ViroMed is a very positive step forward for Cobrabio, providing a strong medium to long term business forecast. Having worked closely with ViroMed to develop a successful manufacturing process for its plasmid DNA product we are delighted to enter into a long term agreement, with a broad scope that will bring significant benefits to both parties.”